Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, May 10, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
David Hoang Maintained (XENE) at Strong Buy with Decreased Target to $60 on, May 10th, 2024
David Hoang of Citigroup, Maintained "Xenon Pharmaceuticals Inc." (XENE) at Strong Buy with Decreased Target from $62 to $60 on, May 10th, 2024.
David has made no other calls on XENE in the last 4 months.
There are 2 other peers that have a rating on XENE. Out of the 2 peers that are also analyzing XENE, 0 agree with David's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with David
- Josh Schimmer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $65 on, Wednesday, April 10th, 2024
- Brian Abrahams of "RBC Capital" Maintained at Buy with Decreased Target to $55 on, Friday, March 1st, 2024
